These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 26950237)

  • 1. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.
    Cheng SC; Scicluna BP; Arts RJ; Gresnigt MS; Lachmandas E; Giamarellos-Bourboulis EJ; Kox M; Manjeri GR; Wagenaars JA; Cremer OL; Leentjens J; van der Meer AJ; van de Veerdonk FL; Bonten MJ; Schultz MJ; Willems PH; Pickkers P; Joosten LA; van der Poll T; Netea MG
    Nat Immunol; 2016 Apr; 17(4):406-13. PubMed ID: 26950237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline Science: Endotoxin-induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst.
    Grondman I; Arts RJW; Koch RM; Leijte GP; Gerretsen J; Bruse N; Kempkes RWM; Ter Horst R; Kox M; Pickkers P; Netea MG; Gresnigt MS
    J Leukoc Biol; 2019 Jul; 106(1):11-25. PubMed ID: 31169935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors.
    Seeley JJ; Baker RG; Mohamed G; Bruns T; Hayden MS; Deshmukh SD; Freedberg DE; Ghosh S
    Nature; 2018 Jul; 559(7712):114-119. PubMed ID: 29950719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity.
    Domínguez-Andrés J; Novakovic B; Li Y; Scicluna BP; Gresnigt MS; Arts RJW; Oosting M; Moorlag SJCFM; Groh LA; Zwaag J; Koch RM; Ter Horst R; Joosten LAB; Wijmenga C; Michelucci A; van der Poll T; Kox M; Pickkers P; Kumar V; Stunnenberg H; Netea MG
    Cell Metab; 2019 Jan; 29(1):211-220.e5. PubMed ID: 30293776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.
    Delsing CE; Gresnigt MS; Leentjens J; Preijers F; Frager FA; Kox M; Monneret G; Venet F; Bleeker-Rovers CP; van de Veerdonk FL; Pickkers P; Pachot A; Kullberg BJ; Netea MG
    BMC Infect Dis; 2014 Mar; 14():166. PubMed ID: 24669841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic Acid Inhibits Lipopolysaccharide-Induced Mast Cell Function by Limiting Glycolysis and ATP Availability.
    Caslin HL; Abebayehu D; Abdul Qayum A; Haque TT; Taruselli MT; Paez PA; Pondicherry N; Barnstein BO; Hoeferlin LA; Chalfant CE; Ryan JJ
    J Immunol; 2019 Jul; 203(2):453-464. PubMed ID: 31160535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokines increase the rate of glycolysis and adenosine-5'-triphosphate turnover in cultured rat enterocytes.
    Berg S; Sappington PL; Guzik LJ; Delude RL; Fink MP
    Crit Care Med; 2003 Apr; 31(4):1203-12. PubMed ID: 12682494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of endotoxemia in sepsis varies in relation to the underlying infection: Impact on final outcome.
    Kritselis I; Tzanetakou V; Adamis G; Anthopoulos G; Antoniadou E; Bristianou M; Kotanidou A; Lignos M; Polyzos K; Retsas T; Sassopoulou P; Papaioannou AI; Sinapidis D; Sereti K; Vittoros V; Ghanas P; Gogos C; Giamarellos-Bourboulis EJ
    Immunol Lett; 2013 May; 152(2):167-72. PubMed ID: 23747516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
    Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous HMGB1 is required in endotoxin tolerance.
    Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
    J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.
    Heinbockel L; Marwitz S; Barcena Varela S; Ferrer-Espada R; Reiling N; Goldmann T; Gutsmann T; Mier W; Schürholz T; Drömann D; Brandenburg K; Martinez de Tejada G
    PLoS One; 2015; 10(7):e0133291. PubMed ID: 26197109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance.
    Novakovic B; Habibi E; Wang SY; Arts RJW; Davar R; Megchelenbrink W; Kim B; Kuznetsova T; Kox M; Zwaag J; Matarese F; van Heeringen SJ; Janssen-Megens EM; Sharifi N; Wang C; Keramati F; Schoonenberg V; Flicek P; Clarke L; Pickkers P; Heath S; Gut I; Netea MG; Martens JHA; Logie C; Stunnenberg HG
    Cell; 2016 Nov; 167(5):1354-1368.e14. PubMed ID: 27863248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis.
    Lee SJ; Gharbi A; You JS; Han HD; Kang TH; Hong SH; Park WS; Jung ID; Park YM
    Int Immunopharmacol; 2019 Aug; 73():482-490. PubMed ID: 31173970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and murine macrophages exhibit differential metabolic responses to lipopolysaccharide - A divergent role for glycolysis.
    Vijayan V; Pradhan P; Braud L; Fuchs HR; Gueler F; Motterlini R; Foresti R; Immenschuh S
    Redox Biol; 2019 Apr; 22():101147. PubMed ID: 30825774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ.
    Tissières P; Ochoda A; Dunn-Siegrist I; Drifte G; Morales M; Pfister R; Berner M; Pugin J
    PLoS One; 2012; 7(3):e32863. PubMed ID: 22427899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro.
    Bode C; Diedrich B; Muenster S; Hentschel V; Weisheit C; Rommelsheim K; Hoeft A; Meyer R; Boehm O; Knuefermann P; Baumgarten G
    Int Immunopharmacol; 2014 Jan; 18(1):27-34. PubMed ID: 24239744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CD40 endogenous S-nitrosylation during inflammatory response in endotoxemic mice and patients with sepsis.
    Godoy LC; Moretti AI; Jurado MC; Oxer D; Janiszewski M; Ckless K; Velasco IT; Laurindo FR; Souza HP
    Shock; 2010 Jun; 33(6):626-33. PubMed ID: 20473113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
    Sullivan GW; Fang G; Linden J; Scheld WM
    J Infect Dis; 2004 May; 189(10):1897-904. PubMed ID: 15122527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuin1 Targeting Reverses Innate and Adaptive Immune Tolerance in Septic Mice.
    Martin AN; Alexander-Miller M; Yoza BK; Vachharajani V; McCall CE
    J Immunol Res; 2018; 2018():2402593. PubMed ID: 30069485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers.
    van Eijk LT; Dorresteijn MJ; Smits P; van der Hoeven JG; Netea MG; Pickkers P
    Crit Care Med; 2007 Jun; 35(6):1464-9. PubMed ID: 17452928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.